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Purpose: Primary open-angle glaucoma is a leading cause of blindness worldwide. We previously identified a region on
chromosome 20p12 associated with juvenile-onset primary open-angle glaucoma (JOAG) that was designated GLC1K.
The aim of this study is to refine the boundaries of the GLC1K region and to screen selected candidate genes located
within the refined region for biologically significant mutations.
Methods: Four JOAG families (44 individuals) with linkage to GLC1K were used for this study. Informative single
nucleotide polymorphism (SNP) markers located throughout the previously defined region were used for haplotype
analysis. Four candidate genes within the refined region were screened for biologically significant mutations using direct
genomic sequencing: bone morphogenetic protein 2 (BMP2); phospholipase C beta 1 (PLCB1); phospholipase C beta 4
(PLCB4); and BTB POZ domain containing 3 (BTBD3).
Results: Haplotype analysis identified a new critical interval of 12.7 Mb using a combination of SNPs and microsatellite
markers. This analysis extended the region of GLC1K from D20S846 to rs6081603 in affected individuals, and the region
was further reduced to 9 Mb if unaffected recombinant individuals were included in the analysis. Biologically significant
DNA sequence variants were not identified in the BMP2, PLCB1, PLCB4, or BTBD3 genes in these families.
Conclusions: Using recombinant breakpoint mapping and haplotypes based on a combination of SNP and microsatellite
markers, the GLC1K region has been reduced to a maximum of 12.7 Mb and a minimum of 9 Mb. Four genes that are
located within the refined region with attractive ocular expression and function have been excluded as causative genes
for JOAG.
Glaucoma  is  the  principal  cause  of  optic  nerve
degeneration  and  the  second  leading  cause  of  blindness
worldwide. The disease is predicted to affect more than 50
million people including more than 3 million people in the
United States by the year 2020 [1,2]. All forms of glaucoma
are characterized by a loss of retinal ganglion cells, leading to
optic  nerve  degeneration  and  corresponding  visual  field
defects [3]. Unless the disease is identified and therapeutic
intervention  is  begun  at  an  early  stage,  individuals  with
glaucoma develop irreversible blindness. Primary open-angle
glaucoma (POAG; OMIM 137760) is the most common form
of glaucoma and is associated with an open chamber angle
and normal-appearing trabecular meshwork. The prevalence
of POAG is low in persons under the age of 50 but increases
significantly after the age of 70 [4-6]. Juvenile open-angle
glaucoma (JOAG) is a rarer subset of POAG that develops
before the age of 40 [7].
A family history of glaucoma is widely recognized as a
major risk factor for the disease, suggesting that specific gene
defects  contribute  to  the  pathogenesis  [8].  Indeed,  both
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Mendelian and non-Mendelian forms of inheritance have been
described; the more common adult-onset form of POAG has
heritability consistent with that of a complex trait while JOAG
exhibits autosomal dominant inheritance [9,10].
Linkage approaches using large pedigrees affected by
POAG have lead to the identification of 14 major genetic loci
for adult-onset POAG (GLC1A-GLC1N) [11-14] and three
genes that contribute to POAG have been identified. Myocilin
(MYOC, GLC1A, OMIM 601652) is responsible for 20% of
patients with JOAG [15] and 3%–5% of POAG, optineurin
(OPTN, GLC1E, OMIM 602432) [16] is primarily associated
with  low  tension  glaucoma,  and  WD  repeat  domain  36
(WDR36, GLC1G, OMIM 609669) [17] may be a modifying
factor that can influence the severity of disease [18]. None of
the disease-associated DNA sequence variants in any of these
genes are responsible for a significant fraction of the disease
in the POAG population [16-25]. These results highlight the
multifactorial inheritance of POAG and point to the existence
of additional loci and genes that can contribute to this complex
disease [10,11].
Six  of  the  open-angle  glaucoma  loci  are  primarily
associated with early onset open-angle glaucoma or JOAG:
GLC1A, GLC1J, GLC1K, GLC1M, GLC1N, and a novel
region on 2p15–16 that partially overlaps with GLC1H [12,
13,15,26-28]. We previously performed a genome-wide scan
using 25 JOAG families that identified two novel JOAG loci
Molecular Vision 2008; 14:1319-1326 <http://www.molvis.org/molvis/v14/a159>
Received 16 May 2008 | Accepted 14 July 2008 | Published 21 July 2008
© 2008 Molecular Vision
1319on 9q22 (GLC1J) and 20p12 (GLC1K) [26]. In our previous
study,  haplotype  analysis  of  15  families  identified  seven
families with consistent linkage to the GLC1J region, five
families with consistent linkage to the GLC1K region, and
three  families  with  consistent  linkage  to  both  regions.
Recombination  events  identified  a  9  cM  region  on
chromosome  9  between  markers  D9S1841  and  D9S271
(GLC1J) and a 46 cM region on chromosome 20 between
markers D20S846 and D20S891 (GLC1K). The purpose of
the current study is to saturate the GLC1K region with single
nucleotide  polymorphism  (SNP)  markers  making  further
definition of the boundaries of the critical recombinant region
possible and to screen candidate genes located in the refined
region for biologically significant mutations.
METHODS
Families: This study adhered to the tenets of the Declaration
of  Helsinki  and  has  been  reviewed  and  approved  by  the
Institutional Review Board of the Massachusetts Eye and Ear
Infirmary.  Four  JOAG  families  (44  individuals)  with
previously demonstrated linkage to GLC1K were used for this
study. All of these families demonstrated inheritance patterns
consistent  with  autosomal  dominant  inheritance  and  had
sufficient size and structure that haplotype analysis could be
performed  using  all  four  of  the  original  parental
chromosomes. All of the sampled family members (affected
and  unaffected)  who  entered  into  this  study  underwent  a
complete  ocular  examination  including  gonioscopy,
tonometry, and fundoscopy. All affected individuals also had
visual field testing using the automated Humphrey perimeter.
Affected  individuals  met  the  following  three  criteria:  1)
intraocular pressure measured by applanation tonometry in
both eyes was greater than 22 mmHg or greater than 19 mmHg
on two glaucoma medications, 2) there was glaucomatous
optic neuropathy in both eyes, and 3) visual field loss was
consistent  with  optic  nerve  damage  in  at  least  one  eye.
Juvenile open-angle glaucoma (JOAG) is defined as patients
who meet these criteria and have an age of onset before the
age of 40 while adult onset primary open-angle glaucoma
patients meet the above criteria and have an age of onset after
the age of 40 [7]. Glaucomatous optic neuropathy was defined
as a cup to disk ratio higher than 0.7 or focal loss of the nerve
fiber layer associated with a visual field defect. The affected
family members had normal appearing angle structures on
gonioscopy, and none of the affected family members had any
evidence  of  secondary  glaucomas  including  pigment
dispersion,  anterior  segment  dysgenesis,  and  corneal
abnormalities.
Genotyping:  Genomic  DNA  was  prepared  from  blood
samples from family members using previously described
techniques  [18].  SNP  genotyping  was  performed  using  a
quantitative  polymerase  chain  reaction  (PCR)  approach
(TaqMan  Assay;  Applied  Biosystems,  Foster  City,  CA)
according  to  the  manufacturer’s  instructions.  The  reverse
transcription  polymerase  chain  reaction  (RT–PCR)
amplification of genomic DNA was performed in a 96 well
plate with a sequence detection system (ABI Prism©7000
Sequence Detection System; Applied Biosystems Inc., Foster
City,  CA).  The  thermal  cycler  (model  2720,  Applied
Biosystems Inc., Foster City, CA) was set at the following
parameters: 50 °C for 2 min, 95 °C for 10 min, 92 °C for 15
s, and 58 °C for 1 min for a total of 60 cycles. Microsatellite
genotypes had been previously obtained [26].
Haplotype analysis: Forty SNPs with minor allele frequency
greater than 40% were chosen at approximately 100,000 base
pair  intervals  throughout  the  previously  defined  GLC1K
region  [29].  Alleles  from  informative  SNP  markers  were
added  to  previously  established  microsatellite-based
haplotypes [26]. Haplotypes were deduced initially using the
Simwalk 2 program [30]. These haplotypes were confirmed
by visual inspection, and ambiguities in transmission were
resolved where possible.
DNA sequencing: All exons and 100 base pairs of the flanking
intron  sequence  were  sequenced  for  bone  morphogenetic
protein  2  (BMP2);  phospholipase  C  beta  1  (PLCB1);
phospholipase C beta 4 (PLCB4); and BTB POZ domain
containing  3  (BTBD3)  using  nested  PCR  strategies  for
amplification.  Oligonucleotides  for  amplification  and
sequencing were selected using Primer3 software (provided
by Massachusetts Institute of Technology, Cambridge, MA)
and were located at least 40 bp from each exon’s splice site.
Primer  sequences  are  presented  in  Table  1.  PCR  was
performed in a thermal cycler in a total volume of 25 μl
containing 50 ng genomic DNA; 1.5 mM MgCl2; 200 μM each
of  dATP,  dCTP,  dGTP,  and  dTTP;  100  ng  forward  PCR
primer, 100 ng reverse PCR primer; 20 mM Tris-HCl (pH
8.4); 50 mM KCl; and 0.5 U Taq DNA polymerase (Platinum
Taq; Invitrogen-Life Technologies, Rockville, MD). Cycling
conditions were as follows: an initial denaturing step of 5 min
at 94 °C; 35 cycles of denaturation (94 °C for 45 s), annealing
(primer-specific annealing temperature for 60 s), elongation
(72 °C for 45 s), and a final elongation step of 5 min at 72 °C.
Amplified  genomic  DNA  was  directly  sequenced  using
sequencing  chemistries  (BIGDYE  version  3.1;  Applied
Biosystems Inc.) and an automated sequencer (model 3100;
Applied Biosystems Inc.). Sequences were analyzed using
sequencer software (Gene Codes Corp., Ann Arbor, MI) and
compared to the gene sequence in the public database [31,
32].
RESULTS
Reduction of the GLC1K critical interval: The GLC1K region
was  previously  identified  as  a  glaucoma  gene  locus  by  a
microsatellite-based genome scan using a population of 25
multi-generational JOAG pedigrees (overall multipoint LOD
score  of  4.0)  [26].  Haplotypes  that  were  based  on  the
microsatellite repeat markers used in the scan identified key
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1320TABLE 1. OLIGONUCLEOTIDE PRIMERS.
Gene Exon Forward primer Reverse primer Sequence primer
BMP2 1A ggaacttgggacccttcatt agtgcctgcgatacaggtct ttgagcttcggtcggtctta
1B cttctagcgttgctgcttcc ccaccacacaagcagtgagt tcctgagcgagttcgagttg
2A atcaaatcccacgatgaggt cacttccaccacgaatccat tcaaacgtcattacttggct
2B aaacctgcaacagccaactc ctcgtcaaggtacagcatcg ggtgaatcagaatgcaagca
2C gagacaccctttgtacgtgga tacttcatgtgctggggttg atcatctgaactccactaat
PLCB1 1 ggcttctcttcgccttcc agtgcgcccattgcataac tccggagcagagaaaggagc
2 ggaaagaacctcagttacataatgg gactttgaaacgtcctaagtcct tgactactttggagaatctg
3 tgatttaggaatggcttgtagga gggcatactggctattgtgtt cttcagtcaagtctcaagat
4 tacctctgggcaagttgctt gcacttatacttggcagctgaa cattctaactcaacagaagt
5 aaagaacatctcctttggaaaa gtgcagcttggaggaaagag gaactaatgtgtcttcctgg
6 ggcttctggaatgctgctaa gcatttccacactcccactt ttaatctgggtgccaactgt
7 atgcaaatgcatggaggaa ttcctctccgatgataatcca tgagttggcatcatctgtta
8 ccctaaagccagtgtccaaa gggcaagattgtgtgatcct acgctacggttgacctcata
9 cggtagcaattgcacaagat ccgaaaggaatgccttgtaa aggtatagaaattatggtgg
10 atttggtggggctcatgtaa agagttctcagaggcacttcg taccttggacactacaagat
11 aaattgagccattaccttctgg gcctctgaaattgcaaagatg taactgctgcagctcttaga
12 tccagaatcaagagtcagaattagc gatcctacaagtccaacggataa gatacaattctctgaatgga
13 ttcgctgtccatctgtgtatg caccaactgcattaatcttacca agttaagataaagatccagg
14A ttgggtttctatgttccattg ttccttctgatgacttgtgtga tatggtcttcttcatgtaga
14B tgagcagtgttgaaggtaggg ggatggtctcgaactcctga tagctggaatctggagttcc
15 tgttttcaatgccacgtgtt tcttctccggattgtggaac cttccaaggaaatctgtaat
16 aggtgttgctgttgcctttc tgtgtaaagtaacaaggcagtcaa tctgcatgcttgaatcatgt
17 tctgacccaagtagcaaacg acacagagcttggtggtgtg cctcaacttcactgaatatt
18 tatcccaaagtagcccaacg ttcccttcattgaaatttgctt ggtagcttcttagttactat
19 tctgtgtttcctgcatttctaca gagaacacacggacccctta aagtggactgggatcaactt
20 tgggtgaggacatagaacca ccgtccatttgaggcatact ttgctgaagagcatttgtgg
21 caagatcacgccactgcac ctaaatctcatcgcccttgtt gtcctgattgaataatacct
22 tgacatgtgatttggaattatcttt cgaaagtaggggtgattctga atcacatagatgcgcataat
23 aatgactgggtggatggatg tgctattccttctcccaagg atggtcagatagatgagtaa
24 cgggcatagacataggttgg ggagctcctcctaagtccaca tggctcaacactatgctgtt
25 actgcacctggcctaatgtt ttttatgccagtagggttctagc agagatttagattcaaggcc
26 cccaggtagagctgacatcaa aaagctatggagaacggaggt ttgctcttaaactctagctg
27 ttcagtctctgggattggaga tctcaagttggtgccagtca aggaattctggtgaataacc
28/29 tggttctaaattgtcctcattgc cacgaaggagtctttgactgg catccatcacagatattcta
30 gcaacagagcgaaaccttgt gcaattcaacttgcagaaatgt aatgttgagagttctgtaac
31 agtgcagtccattgatcacc caccaggtgatgataaatgctta atgtaagccatagatctgaa
32 cctctataggtgaccagtgaatga cttctcgggaagatggtcct gtatatctctttcagagagt
PLCB4 1 cccaaatgatcacctctggt gcctcttttcaacaactccaa gcgaagtgattaaccatcct
2 aacctatcctagagcaagatgtttt gaggataatgtccttaatcatcactg gtttagaagctcagcaatat
3 gcactgccttcatcatcaga gccttttattagggtctgcttg agcagtttgcctgtatcata
4 gaatgcaccactgttcacca cccacaggagtgacatgcta gaataatgctaggtgtctgg
5 atggcacaatagatggcaca gaggaaggaaccacctagcc agatggctgtgtgacaggaa
6 caaccctaaattcatcttatagcaca tttgccacctattttgacca taacagaattgaagctgctc
7 ctaaccagctctgggaacca agctggccttcatttccttt tagtctcactctccatagta
8 tagtgagatggcctggcagt aaagttccaggtgctgcaat gcaggaatcagagatgaaga
9 gggagtgttttccttctgttg gtgcaaagccaatgtgaaga agaattcaccactacttcag
10 ttaaggagaaaggcaggaagg gtcatcaatccatggctcag cagtgaggtcctatctttgt
11 gacagatgaaagttcttgggaaa caacgttaaatgaccatgataatcc gctgcctcagcttccatgaa
12 tgataataccaaccagatgaggaa tgaaggcataatgcttgagaaa ttaacctgtatatgccatga
13 ccacagggaactcaaccttt gtgcccttgctggagaatta ccaggtctgaattgctggaa
14 tctcacattagcattaagaggacaa tgatgtaagctttccgtaccaa gtgagaatctttaattgcct
15 gctctgcacacctctggaa tgtggcaatcttgctctgaa gtttgcagcactagtctaag
16 tcacgaggactgaacctcct attatgggcttgagccactg tgtcgatctcaaggcctagg
17 ccttgacgttgaataggtaagagtt tggccctgactaatgagtaattt tactgcatatatcaatgtcc
18 ctccttttgcattattcagagc ccacataccaaggtggcttc caacagacactaacttctta
19 tctccatccacaggatgtca gccatggtctttcccacata gctactgacatgataatgta
20 catggcagctgtgacaatct ttgctttgccatatgtctgc gaactgtgatcttaagcatc
21 tgccttaaatagaccaagcaga tcccagacataaaatcctcca gcctaggagcaatctgatac
22 ggcacattctcttccatcct aagttgtgagcagcacatgg agctcctgtgttacagatgg
23 gaaggtagaacatctgcttgaaa tgttgtcggttgaataagtgc tgcctatagtagttgttcga
24 tcttgggcactgtagctcat ggcagcattagcaggaataga ggaatgcagatggatcatgg
25 agctgtgccttcctcagtgt gccactgatgatgaagtggat caggtatccaggattgtagt
26 ctttccttggctggatcctt acggcctgtccaggtaacta gtatggtagaagtttactgg
27 tgccctcaatcaatcacttg tgcttcaagtaagcctttgg tcgatgagatttcgatatgt
28 aaggatagaagacttaaagcagatga gcactcccaaaccgattcta ctcaccaagtgtaatcattg
29 tgttgaatgggagatctgga ccttgacctaaacagcagca gtctgtactgttctcagatt
30 aaagaccagtgttgcccaat ccagatcagctgcaggctac gagccatgacatctcatatt
31 aacttcctgcttcccattga tcagccatatgatgagatacacaa tgattcaccaattaagttgg
32 tgagaggagtgagcctagtca gccacaagtgttttgctgtc agtgcatgacattaagtaca
33 tgaatcaggaagaatacacatgg ggagcagagaagctggaatg cttctctggacattatatgt
34 ggtttagtcatgcgtaagtcctc atatgcaagccactggtca tagcaggaaagatcttccca
35 taagaaggtcccaggcaatg cagacattccaagtctctctgg tagcaaggatgtggtgacag
BTBD3 1A caggaatcatgatggggata gcaacttgctgctgttgcta tcagttaacctcttagcccg
1B tgatgcttccagagacggta gcttctgggaaaagaggaaa gcagcaagttgccaccagtt
2 cattcaagtgacagggttgtct aaaattaagcgtggccaaag tgccttgaagttactggact
3 catggcaagctaccctgtgt cccaaattctacgtcaaggtg gcagtagattttaggtacgc
4A gaggctagaatggtagcacaaag acttcagcccagttgagagc gaatgttcctttactctgca
4B ctgttcgaggagccagacct cctgccgcttaagttcaatc tgattgatgcccaggctgag
4C gtcaccgtttccagtcgtgt aattaccggcactgatcaca agcatccagtttgcagttga
Oligonucleotide primers used to PCR amplify each of the indicated exons of BMP2, PLCB1, PLCB4, and BTBD3, along with
the primer sequence used to sequence each PCR product.
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1321Figure 1. GLC1K haplotype analysis in JOAG families. Haplotypes consisting of alleles for microsatellite repeat markers and SNPs are shown
under each individual in the pedigrees. The boxed regions indicate the haplotype that segregates with the affected status. The small arrow
identifies the location of a recombination event on the non-disease chromosome. The UCSC genome browser [27] was used to determine the
location of the markers.
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1322recombination  events  in  affected  members  in  pedigree
JOAG-52, a three-generation family with sufficient size and
structure  to  establish  independent  linkage  to  the  GLC1K
region  (maximum  LOD  score=3.2).  These  recombination
breakpoints defined a 46 cM region extending from marker
D20S846 to marker D20S891 in affected individuals and a 23
cM region extending from marker D20894 to marker D20878
if unaffected individuals were included in the analysis. To
reduce  the  size  of  the  critical  region,  40  SNPs  (single
nucleotide polymorphisms) with minor allele frequencies of
at least 40% were selected at approximately 100 Kb intervals
throughout  the  previously  defined  GLC1K  region  [29].
Fifteen SNPs were informative for haplotype analysis, and
alleles from these SNPs were evaluated for segregation in all
members  of  pedigree  JOAG-52  (Figure  1A).  Haplotype
analysis using the previous microsatellite alleles as well as the
added SNP alleles identified recombination breakpoints that
defined a new critical interval of 12.7 Mb, extending from
marker  D20S846  to  marker  rs6081603,  a  reduction  of
approximately  26  Mb.  The  critical  recombination  events
defining the 12.7 Mb region occurred in individuals II-1 and
II-3, both affected. A third recombination event occurred in
individual  III-5  who  is  unaffected  at  age  45.  This
recombination event would reduce the size of the region to 9
Mb, extending from marker rs1232605 to marker rs6081603.
Because of the unknown penetrance of JOAG, we are using
the most conservative measure for the size of the region of
12.7  Mb,  which  is  based  on  the  recombination  events  in
individuals known to be affected.
To provide additional support for the new critical region,
a  selection  of  SNPs  that  defined  the  shared  haplotype  in
JOAG-52  was  evaluated  in  a  group  of  smaller  pedigrees
(Figure 1B,C) with previous microsatellite-based haplotypes
consistent with linkage to GLC1K. The affected individuals
in each family shared a different haplotype, and none of the
affected individuals had recombination events that led to a
further reduction in the size of the GLC1K critical region.
Evaluation of candidate genes located in the reduced GLC1K
critical interval: The refined GLC1K locus lies within a gene-
rich region on chromosome 20 that contains several genes that
could be considered good candidates for early onset glaucoma
based on their proposed function and tissue expression. Four
of these genes, BMP2, PLCB1, PLCB4, and BTBD3, were
selected for mutation screening. Bone morphogenetic proteins
(BMPs)  are  multifunctional  cytokines  that  have  a  broad
spectrum of activities in various cell types and tissues. In
retinal ganglion cells growing in culture, BMPs increased the
number, length, and branch points of neurites, suggesting that
BMPs function to promote and maintain ganglion cell growth
[33]. Members of the BMP family have also been shown to
be expressed in the human trabecular meshwork and optic
nerve head [34]. BMP2, one member of the BMP family
located within the critical region, was selected for screening
because of the potential role of the protein in the development
TABLE 2. DNA SEQUENCE VARIANTS IN CANDIDATE GENES LOCATED WITHIN THE GLC1K REFINED REGION.
Gene (Mb) Ocular expression Function Sequence variant Family Individual
BMP2 (6.7) Lens, fetal eye Member of TGFB
superfamily
c.1946 C>T D387D
rs13037675
JOAG-25 III-2
c.2220 A>C 3′ UTR JOAG-52 II-1
PLCB1 (8.6) Retina, fetal eye Intracellular
transduction of
extracellular signals
c.105 C>T D34D
rs16994453
JOAG-25 III-2
c.2085 C>T G694G
rs3761170
JOAG-25 III-2
c.2202 A>G V733V
rs8118206
JOAG-52 II-1
c.2568 C>T A855A
rs2076413
JOAG-25 III-2
c.2991 A>G A996A
rs2235613
JOAG-52 II-1
PLCB4 (9.4) Ciliary body, trabecular
meshwork, retina, retinal
pigment epithelium
Intracellular
transduction of
extracellular signals in
the retina
c.197 A>GA21T
rs6077510
JOAG-52                           II-1,
                                          III-2
BTBD3 (11.6) Retina, iris, fetal eye Protein–protein
interaction; DNA
binding protein
c.909 G>A A303A
rs35364034
JOAG-52 II-1
IVS2+12G>A JOAG-52 II-1
The DNA sequence variants identified by genomic sequencing of all exons and flanking intron sequences are shown for each
candidate gene. Expression data are from the Stanford SOURCE database.
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JOAG-25and function of both the trabecular meshwork and the retinal
ganglion cells. PLCB1 and PLCB4 are also located within the
newly defined critical region. PLCB1 has been implicated in
trabecular meshwork function and has been shown to have
reduced levels of expression in glaucomatous ciliary body
cells grown in culture [35] while PLCB4 appears to function
in the retinal visual response [36]. BTBD3 is a member of the
protein family that contains BTB/POZ domains. The BTB/
POZ (broad complex Tramtrack bric-a-brac/Pox virus and
zinc finger) domain is an evolutionarily conserved protein–
protein interaction motif. Many BTB-containing proteins are
transcriptional  regulators  involved  in  a  wide  range  of
developmental processes [37]. Several BTB/POZ homologs
are involved in ocular development and retinal function. Mri
is  a  drosophila  homolog  that  was  initially  identified  in  a
microarray  screen  for  molecules  that  regulate  retinal
apoptosis, the process that retinal ganglion cells undergo in
glaucoma  [38].  Another  BTB/POZ  protein,  Tramtrack69
(Ttk69), block neuronal photoreceptor differentiation when
overexpressed [39]. The entire coding sequence of all four
genes including 100 bases of the 5′ and 3′ untranslated regions
and the flanking intron/exon boundaries was screened for
DNA sequence variants by PCR amplification followed by
direct genomic sequencing in an affected member of each
family with linkage to GLC1K. Ten DNA sequence variants
were detected, although none of these would be predicted to
have significant biological consequences (Table 2). Studies to
detect alterations of gene expression or evaluations of gene
dosage were not carried out.
DISCUSSION
Previous studies using a collection of 25 JOAG pedigrees
identified GLC1K as a juvenile-onset glaucoma locus. In the
present study, using high density SNP markers and haplotype
analysis, we have reduced the size of the GLC1K locus on
chromosome  20  to  12.7  Mb,  a  reduction  of  over  seventy
percent. This reduction in size of the interval is based on
recombination  events  in  affected  individuals  only.  If  a
recombination event in an unaffected individual (JOAG-52,
individual III-5, age 45) is included, the size of the interval is
reduced further to 9 Mb. Within the reduced region, we have
screened four potential disease-causing candidate genes. Ten
sequence variants were identified in JOAG-affected family
members, although none of these are predicted to have a
significant  biological  effect.  Using  a  variety  of  databases
(Stanford Microarray Database [40], UNIgene [41], NEIBank
[42], and UCSC genome browser [31]), we have identified at
least 30 genes within the refined GLC1K region, and of these
genes, 24 have significant ocular expression. These genes will
be prioritized for mutation screening according to the putative
function of the gene product as well as tissue expression.
The  improved  localization  of  GLC1K  has  excluded
several genes that would previously have been considered to
be excellent candidates. These include a group of genes that
could participate in the development of the ocular structures
affected in glaucoma including SOX12 (2.5 Mb), EYA 2 (45
Mb), Sall4 (49 Mb), and VSX1 (25 Mb) [43-46]. The exclusion
of VSX1 is particularly interesting as mutations in this gene
have  been  associated  with  some  cases  of  posterior
polymorphous dystrophy (PPMD), a condition that can be
confused with primary juvenile open-angle glaucoma [46,
47].  One  locus  for  the  oculo-oto-dental  syndrome,  a
developmental ocular syndrome that can involve the anterior
segment of the eye, has been mapped to 20q13 with peak
linkage to D20S836 (44.3 Mb) [48], a location that is distal to
the telomeric boundary of the refined GLC1K region, thus
excluding this locus from further consideration. The reduction
in  size  of  the  GLC1K  region  will  greatly  increase  the
efficiency of screening the remaining candidate genes located
within the refined critical region.
The  identification  and  characterization  of  genes
responsible  for  early  onset  primary  open-angle  glaucoma
(JOAG)  may  help  define  molecular  pathways  that  are
responsible for open-angle glaucoma including the common
adult-onset form of the disease. It is also possible that a gene
that  is  responsible  for  juvenile  onset  primary  open-angle
glaucoma can also contribute to adult forms of the disease as
has been shown for some mutations in the gene coding for
myocilin  [49].  Defining  the  molecular  mechanisms
responsible for glaucoma will lead to a better understanding
of the underlying pathophysiology of the disease and will lead
to novel methods of treatment and diagnosis for this blinding
condition.
ACKNOWLEDGMENTS
We thank the families for participating in this study and also
acknowledge funding support from HHMI (Medical student
fellowship to A.S.), NEI (R01EY009847, P30EY014104),
and RPB (Lew Wasserman Merit Award to J.L.W.).
REFERENCES
1. Quigley HA, Broman AT. The number of people with glaucoma
worldwide  in  2010  and  2020.  Br  J  Ophthalmol  2006;
90:262-77. [PMID: 16488940]
2. Friedman DS, Wolfs RC, O’Colmain BJ, Klein BE, Taylor HR,
West S, Leske MC, Mitchell P, Congdon N, Kempen J, Eye
Diseases Prevalence Research Group. Prevalence of open-
angle  glaucoma  among  adults  in  the  United  States.  Arch
Ophthal 2004; 122:532-8. [PMID: 15078671]
3. Farkas RH, Grosskreutz CL. Apoptosis, neuroprotection, and
retinal ganglion cell death: an overview. Int Ophthalmol Clin
2001; 41:111-30. [PMID: 11198138]
4. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt
J. Racial variation in the prevalence of primary open-angle
glaucoma.  The  Baltimore  Eye  Survey.  JAMA  1991;
266:369-74. [PMID: 2056646]
5. Klein BE, Klein R, Sponsel WE, Franke T, Cantor LB, Martone
J, Menage MJ. Prevalence of glaucoma. The Beaver Dam Eye
Study. Ophthalmology 1992; 99:1499-504. [PMID: 1454314]
Molecular Vision 2008; 14:1319-1326 <http://www.molvis.org/molvis/v14/a159> © 2008 Molecular Vision
13246. Leske MC, Connel AM, Schachat AP, Hyman L. The Barbados
Eye  Study:  prevalence  of  open  angle  glaucoma.  Arch
Ophthalmol 1994; 112:821-9. [PMID: 8002842]
7. Wiggs JL, Del Bono EA, Schauman JS, Hutchinson BT, Walton
DS. Clinical features of five pedigrees genetically linked to
the  juvenile  glaucoma  locus  on  chromosome  1q21-q31.
Ophthalmology 1995; 102:1782-9. [PMID: 9098278]
8. Weih LM, Nanjan M, McCarty CA, Taylor HR. Prevalence and
predictors of open-angle glaucoma: results from the visual
impairment  project.  Ophthalmology  2001;  108:1966-72.
[PMID: 11713063]
9. Wiggs  JL,  Damji  KF,  Haines  JL,  Pericak-Vance  MA,
Allingham RR. The distinction between juvenile and adult-
onset primary open angle glaucoma. Am J Hum Genet 1996;
58:243-4. [PMID: 8554064]
10. Hewitt  AW,  Craig  JE,  Mackey  DA.  Complex  genetics  of
complex traits: the case of primary open-angle glaucoma. Clin
Experiment  Ophthalmol  2006;  34:472-84.  [PMID:
16872346]
11. Wiggs JL. Genetic etiologies of Glaucoma. Arch Ophthal 2007;
125:30-7. [PMID: 17210849]
12. Wang DY, Fan BJ, Chua JK, Tam PO, Leung CK, Lam DS,
Pang CP. A genome-wide scan maps a novel juvenile-onset
primary  open  angle  glaucoma  locus  to  15q.  Invest
Ophthalmol Vis Sci 2006; 47:5315-21. [PMID: 17122119]
13. Fan BJ, Wang DY, Lam DS, Pang CP. Gene mapping for
primary  open  angle  glaucoma.  Clin  Biochem  2006;
39:249-58. [PMID: 16332362]
14. Wiggs  JL,  Allingham  RR,  Hossain  A,  Kern  J,  Auguste  J,
DelBono EA, Broomer B, Graham FL, Hauser M, Pericak-
Vance  M,  Haines  JL.  Genome-wide  scan  for  adult-onset
primary  open  angle  glaucoma.  Hum  Mol  Genet  2000;
9:1109-17. [PMID: 10767336]
15. Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR,
Sunden SL, Nishimura D, Clark AF, Nystuen A, Nichols BE,
Mackey DA, Ritch R, Kalenak JW, Craven ER, Sheffield VC.
Identification  of  a  gene  that  causes  primary  open  angle
glaucoma. Science 1997; 275:668-70. [PMID: 9005853]
16. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados
M,  Heon  E,  Krupin  T,  Ritch  R,  Kreutzer  D,  Crick  RP,
Sarfarazi  M.  Adult-onset  primary  open-angle  glaucoma
caused  by  mutations  in  optineurin.  Science  2002;
295:1077-9. [PMID: 11834836]
17. Monemi S, Spaeth G, DaSilva A, Popinchalk S, Ilitchev E,
Liebmann J, Ritch R, Heon E, Crick RP, Child A, Sarfarazi
M. Identification of a novel adult-onset primary open angle
glaucoma (POAG) gene on 5q22.1. Hum Mol Genet 2005;
14:725-33. [PMID: 15677485]
18. Hauser MA, Allingham RR, Linkroum K, Wang J, LaRocque-
Abramson K, Figueiredo D, Santiago-Turla C, del Bono EA,
Haines JL, Pericak-Vance MA, Wiggs JL. Distribution of
WDR36 DNA sequence variants in patients with primary
open-angle  glaucoma.  Invest  Ophthalmol  Vis  Sci  2006;
47:2542-6. [PMID: 16723468]
19. Wiggs JL, Allingham RR, Vollrath D, Jones KH, De La Paz M,
Kern J, Patterson K, Babb VL, Del Bono EA, Broomer BW,
Pericak-Vance MA, Haines JL. Prevalence of mutations in
TIGR/Myocilin in patients with adult and juvenile primary
open-angle glaucoma. Am J Hum Genet 1998; 63:1549-52.
[PMID: 9792882]
20. Fingert JH, Heon E, Liebman JM, Yamamoto T, Craig JE, Rait
J, Kawase K, Hoh ST, Buys YM, Dickinson J, Hockey RR,
Williams-Lyn D, Trope G, Kitazawa Y, Ritch R, Mackey DA,
Alward WL, Sheffield VC, Stone EM. Analysis of myocilin
mutations  in  1703  glaucoma  patients  from  five  different
populations.  Hum  Mol  Genet  1999;  8:899-905.  [PMID:
10196380]
21. Bruttini M, Longo I, Frezzoti P, Ciappetta R, Randazzo A,
Orzalesi N, Fumagalli E, Caporossi A, Frezzotti R, Renieri
A. Mutations in the myocilin gene in families with primary
open-angle  glaucoma  and  juvenile  open-angle  glaucoma.
Arch Ophthalmol 2003; 121:1034-103. [PMID: 12860809]
22. Alward  WL,  Kwon  YH,  Kawase  K,  Craig  JE,  Hayreh  SS,
Johnson AT, Khanna CL, Yamamoto T, Mackey DA, Roos
BR, Affatigato LM, Sheffield VC, Stone EM. Evaluation of
optineurin sequence variations in 1,048 patients with open-
angle  glaucoma.  Am  J  Ophthalmol  2003;  136:904-10.
[PMID: 14597044]
23. Wiggs JL, Auguste J, Allingham RR, Flor JD, Pericak-Vance
MA, Rogers K, LaRocque KR, Graham FL, Broomer B, Del
Bono  E,  Haines  JL,  Hauser  M.  Lack  of  association  of
mutations in optineurin with disease in patients with adult-
onset  primary  open-angle  glaucoma.  Arch  Ophthal  2003;
121:1181-3. [PMID: 12912697]
24. Tang S, Toda Y, Kashiwagi K, Mabuchi F, Iijima H, Tsukahara
S, Yamagata Z. The association between Japanese primary
open-angle glaucoma and normal tension glaucoma patients
and  the  optineurin  gene.  Hum  Genet  2003;  113:276-9.
[PMID: 12811537]
25. Leung YF, Fan BJ, Lam DS, Lee WS, Tam PO, Chua JK, Tham
CC, Lai JS, Fan DS, Pang CP. Different optineurin mutation
pattern in primary open-angle glaucoma. Invest Ophthalmol
Vis Sci 2003; 44:3380-4. [PMID: 12939304]
26. Wiggs JL, Lynch S, Ynagi G, Maselli M, Auguste J, Del Bono
EA, Olson LM, Haines JL. A genomewide scan identifies
novel early-onset primary open angle glaucoma loci on 9q22
and 20p12. Am J Hum Genet 2004; 74:1314-20. [PMID:
15108121]
27. Sheffield VC, Stone EM, Alward WL, Drack AV, Johnson AT,
Streb LM, Nichols BE. Genetic linkage of familial open angle
glaucoma  to  chromosome  1q21-q31.  Nat  Genet  1993;
4:47-50. [PMID: 8513321]
28. Lin Y, Liu T, Li J, Yang J, Du Q, Wang J, Yang Y, Liu X, Fan
Y, Lu F, Chen Y, Pu Y, Zhang K, He X, Yang Z. A genome-
wide scan maps a novel autosomal dominant juvenile-onset
open-angle  glaucoma  locus  to  2p15–16.  Mol  Vis  2008;
14:739-44. [PMID: 18432317]
29. De La Vega FM, Isaac HI, Scafe CR. A tool for selecting SNPs
for  association  studies  based  on  observed  linkage
disequilibrium patterns. Pac Symp Biocomput 2006:487-98.
[PMID: 17094263]
30. Sobel  E,  Sengul  H,  Weeks  DE.  Multipoint  estimation  of
identity-by-descent probabilities at arbitrary positions among
marker  loci  on  general  pedigrees.  Hum  Hered  2001;
52:121-31. [PMID: 11588394]
31. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH,
Zahler AM, Haussler D. The Human Genome Browser at
UCSC. Genome Res 2002; 12:996-1006. [PMID: 12045153]
Molecular Vision 2008; 14:1319-1326 <http://www.molvis.org/molvis/v14/a159> © 2008 Molecular Vision
132532. International Human Genome Sequencing Consortium. Initial
sequencing and analysis of the human genome. Nature 2001;
409:860-921. [PMID: 11237011]
33. Kerrison  JB,  Lewis  RN,  Otteson  DC,  Zack  DJ.  Bone
morphogenetic proteins promote neurite outgrowth in retinal
ganglion cells. Mol Vis 2005; 11:208-15. [PMID: 15788999]
34. Wordinger RJ, Agarwal R, Talati M, Fuller J, Lambert W, Clark
AF. Expression of bone morphogenetic proteins (BMP), BMP
receptors, and BMP associated proteins in human trabecular
meshwork and optic nerve head cells and tissues. Mol Vis
2002; 8:241-50. [PMID: 12131877]
35. Husain S, Kaddour-Djebbar I, Abdel-Latif AA. Alterations in
arachidonic  acid  release  and  phospholipase  C-beta(1)
expression  in  glaucomatous  human  ciliary  muscle  cells.
Invest  Ophthalmol  Vis  Sci  2002;  43:1127-34.  [PMID:
11923256]
36. Jiang H, Lyubarsky A, Dodd R, Vardi N, Pugh E, Baylor D,
Simon MI, Wu D. Phospholipase C beta 4 is involved in
modulating the visual response in mice. Proc Natl Acad Sci
USA 1996; 93:14598-601. [PMID: 8962098]
37. Collins T, Stone JR, Williams AJ. All in the family: the BTB/
POZ,  KRAB,  and  SCAN  domains.  Mol  Cell  Biol  2001;
21:3609-15. [PMID: 11340155]
38. Rusconi JC, Challa U. Drosophila Mrityu encodes a BTB/POZ
domain-containing  protein  and  is  expressed  dynamically
during development. Int J Dev Biol 2007; 51:259-63. [PMID:
17486548]
39. Wen Y, Nguyen D, Li Y, Lai ZC. The N-terminal BTB/POZ
domain  and  C-terminal  sequences  are  essential  for
Tramtrack69 to specify cell fate in the developing Drosophila
eye. Genetics 2000; 156:195-203. [PMID: 10978285]
40. Marinelli RJ, Montgomery K, Liu CL, Shah NH, Prapong W,
Nitzberg M, Zachariah ZK, Sherlock GJ, Natkunam Y, West
RB, van de Rijn M, Brown PO, Ball CA. The Stanford Tissue
Microarray Database. Nucleic Acids Res 2008; 36:D871-7.
[PMID: 17989087]
41. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K,
Chetvernin V, Church DM, Dicuccio M, Edgar R, Federhen
S, Feolo M, Geer LY, Helmberg W, Kapustin Y, Khovayko
O, Landsman D, Lipman DJ, Madden TL, Maglott DR, Miller
V, Ostell J, Pruitt KD, Schuler GD, Shumway M, Sequeira E,
Sherry ST, Sirotkin K, Souvorov A, Starchenko G, Tatusov
RL,  Tatusova  TA,  Wagner  L,  Yaschenko  E.  Database
resources  of  the  National  Center  for  Biotechnology
Information. Nucleic Acids Res 2008; 36:D13-21. [PMID:
18045790]
42. Wistow G. The NEIBank project for ocular genomics: data-
mining gene expression in human and rodent eye tissues. Prog
Retin Eye Res 2006; 25:43-77. [PMID: 16005676]
43. Dy P, Penzo-Méndez A, Wang H, Pedraza CE, Macklin WB,
Lefebvre  V.  The  three  SoxC  proteins–Sox4,  Sox11  and
Sox12–exhibit  overlapping  expression  patterns  and
molecular properties. Nucleic Acids Res 2008; 36:3101-17.
[PMID: 18403418]
44. Ishihara  T,  Ikeda  K,  Sato  S,  Yajima  H,  Kawakami  K.
Differential expression of Eya1 and Eya2 during chick early
embryonic  development.  Gene  Expr  Patterns  2008;
8:357-67. [PMID: 18316249]
45. Harvey SA, Logan MP. sall4 acts downstream of tbx5 and is
required  for  pectoral  fin  outgrowth.  Development  2006;
133:1165-73. [PMID: 16501170]
46. Héon E, Greenberg A, Kopp KK, Rootman D, Vincent AL,
Billingsley G, Priston M, Dorval KM, Chow RL, McInnes
RR, Heathcote G, Westall C, Sutphin JE, Semina E, Bremner
R,  Stone  EM.  VSX1:  a  gene  for  posterior  polymorphous
dystrophy  and  keratoconus.  Hum  Mol  Genet  2002;
11:1029-36. [PMID: 11978762]
47. Shimizu S, Krafchak C, Fuse N, Epstein MP, Schteingart MT,
Sugar A, Eibschitz-Tsimhoni M, Downs CA, Rozsa F, Trager
EH, Reed DM, Boehnke M, Moroi SE, Richards JE. A locus
for posterior polymorphous corneal dystrophy (PPCD3) maps
to chromosome 10. Am J Med Genet A 2004; 130A:372-7.
[PMID: 15384081]
48. Vieira H, Gregory-Evans K, Lim N, Brookes JL, Brueton LA,
Gregory-Evans CY. First genomic localization of oculo-oto-
dental syndrome with linkage to chromosome 20q13.1. Invest
Ophthalmol Vis Sci 2002; 43:2540-5. [PMID: 12147582]
49. Hewitt AW, Mackey DA, Craig JE. Myocilin allele-specific
glaucoma  phenotype  database.  Hum  Mutat  2008;
29:207-11. [PMID: 17966125]
Molecular Vision 2008; 14:1319-1326 <http://www.molvis.org/molvis/v14/a159> © 2008 Molecular Vision
The print version of this article was created on 16 July 2008. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
1326